Related Experiment Videos
Artificial Intelligence in Oncology: Practical Applications Across Clinical Care, Scholarship, and Translation
Jasmin Hundal1, Abhinav Anand Vayal Veettil2, Caroline Chung3
1Department of Hematology and Oncology, Cleveland Clinic Foundation, Cleveland, OH.
None:
Artificial intelligence (AI) is increasingly integrated into oncology across clinical care, research workflows, and translational implementation. This chapter provides a practical overview of these domains, emphasizing opportunities and limitations relevant to real-world oncology practice. In clinical care, AI applications include ambient documentation systems, decision support tools, and remote monitoring platforms. These technologies may reduce administrative burden, assist with evidence synthesis and guideline navigation, and enable longitudinal assessment of symptoms and functional status through wearable and patient-reported data. Emerging tools such as large language models also support patient communication through education, translation, and symptom triage. However, across these applications, performance remains dependent on data quality, validation, and appropriate clinical oversight. In research and scholarship, AI is increasingly used to support grant development, study design, literature review, and manuscript preparation. These tools may improve efficiency, enhance clarity, and assist in identifying research gaps or methodological approaches. At the same time, concerns regarding accuracy, hallucinated content, data privacy, and ethical responsibility require careful oversight. The responsibility for hypothesis generation, methodological rigor, and scientific integrity remains with the investigator. From a translational perspective, a persistent gap exists between model development and clinical deployment. Differences in data quality, infrastructure, and patient populations may limit generalizability, while workflow integration, clinician readiness, and bias mitigation remain critical challenges. Collectively, AI has the potential to enhance oncology care and research, but its impact depends on rigorous validation, equitable implementation, and sustained human oversight.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...